<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4331002 Figure_1-A</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Endogenous PIPKI&#947;i5 and LAPTM4B were immunoprecipitated from the whole&#8208;cell lysates of MDA&#8208;MB&#8208;231 cells followed by immunoblotting to examine the co&#8208;immunoprecipitatedPIPKI&#947;i5 and LAPTM4B.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_1-B</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B PIPKI&#947;i5 specifically interacts with LAPTM4B, but not LAPTM4A or LAPTM5. Top: schematic diagram of all three LAPTM members. Bottom: each Flag&#8208;tagged LAPTM protein was immunoprecipitated from HEK293 cells cotransfected with Myc&#8208;tagged PIPKI&#947;i5 and empty vector or Flag&#8208;tagged LAPTM, and the co&#8208;immunoprecipitatedPIPKI&#947;i5 was examined by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_1-C</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C LAPTM4B selectively associates with PIPKI&#947;i5. Top: schematic diagram of four PIPKI isoforms. Bottom: Myc&#8208;tagged PIPKI&#947;i5 was immunoprecipitated from HEK293 cells expressing Flag&#8208;tagged LAPTM4B and each isoform of PIPKI, followed by immunoblotting to examine the co&#8208;immunoprecipitatedLAPTM4B.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_1-D</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Kinase activity of PIPKI&#947;i5 is required for LAPTM4B association. HEK293 cells expressing LAPTM4B and wild&#8208;type (WT) or kinase&#8208;dead (KD) PIPKI&#947;i5 were starved overnight, stimulated or not with 100 ng/ml EGF for 15 min, and harvested for immunoprecipitation with anti&#8208;myc. The co&#8208;immunoprecipitatedLAPTM4B was detected by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_1-E-F</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 1-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E Endogenous LAPTM4B is targeted to both early and late endosomes. MDA&#8208;MB&#8208;231 cells were fixed and costained for endogenous LAPTM4B (red) and EEA1 or LAMP1 (green). Boxes are selected regions for magnified view. Note: non&#8208;specific nuclear staining by the LAPTM4B anti&#8208;sera. Scale bar: 10 &#956;m. F Quantification of LAPTM4B colocalization with EEA1 and LAMP1 (mean + SD; n &#8805; 4).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_1-H</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 1-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-H</infon>
    <passage>
      <offset>0</offset>
      <text>H LAPTM4B partially colocalizes with PIPKI&#947;i5. MDA&#8208;MB&#8208;231 cells expressing Myc&#8208;tagged PIPKI&#947;i5 were stained with LAPTM4B anti&#8208;sera (red), anti&#8208;Myc (green), and DAPI. Box is selected region for magnified view. Scale bar: 10 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_1-I</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 1-I</infon>
    <infon key="sourcedata_figure_dir">Figure_1-I</infon>
    <passage>
      <offset>0</offset>
      <text>I MDA&#8208;MB&#8208;231 cells stably expressing Flag&#8208;LAPTM4B were stained with LAPTM4B anti&#8208;sera followed by silver&#8208;enhanced immuno&#8208;electron microscopy. The early and late MVEs were defined by the number of intraluminal vesicles. N, nucleus; M, mitochondria; MVE, multi&#8208;vesicular endosome; and PM, plasma membrane. Scale bars: 2 &#956;m (left); 200 nm (middle and right).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_2-A-D</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 2-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>A MDA&#8208;MB&#8208;231 cells transfected with control or LAPTM4B siRNA were starved and stimulated with 100 ng/ml EGF for indicated time periods, followed by whole&#8208;cell lysate harvest for immunoblotting analysis of EGFR levels. B-D Quantification of the levels of EGFR (B), pEGFR (Y1068)(C), and pAKT (S473)(D) from the analysis in (A) (mean &#177; SD; n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_2-E-F-G</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 2-E-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>E Control or LAPTM4B siRNA&#8208;transfected MDA&#8208;MB&#8208;231 cells were starved, pulsed with 25 ng/ml Alexa&#8208;555&#8208;EGF for 3 min, washed, and chased for indicated time periods followed by fixation, DAPI staining, and fluorescence microscopy. Scale bar: 10 &#956;m. F Quantification of the relative amounts of Alexa&#8208;555&#8208;EGF internalized in the indicated conditions (mean + SD, n = 3). G Quantification of the Alexa&#8208;555&#8208;EGF degradation in control and LAPTM4B knockdown cells in (E) (mean &#177; SD, n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_2-H-K</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 2-H-K</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H-K</infon>
    <passage>
      <offset>0</offset>
      <text>H Control or LAPTM4B&#8208;overexpressing MDA&#8208;MB&#8208;231 cells were starved and then stimulated with 100 ng/ml EGF for 1-4 h. EGFR degradation and signaling were analyzed by Western blot. Specific antibodies recognizing pEGFR (Y1068) and pAKT (S473) were used. I-K Quantification for the levels of EGFR (I) and pEGFR (J) normalized to actin and pAKT (K) normalized to AKT in control or LAPTM4B&#8208;overexpressing cells (mean &#177; SD, n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_3-A-D</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 3-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-D Control or LAPTM4B siRNA&#8208;transfected MDA&#8208;MB&#8208;231 cells were starved, pretreated or not with chloroquine for 2 h, stimulated with 100 ng/ml EGF for 15 min, washed, and chased for indicated time periods before fixation for costaining of EGFR (red) with EEA1 (A, green) or LAMP1 (C, green). Quantification of the average percentages of EGFR signals colocalized with EEA1 (B) and LAMP1 (D) at indicated time points; mean + SD; n = 3; *P 0.05, **P 0.01, ***P 0.001, one&#8208;tailed t&#8208;test.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_3-E-F</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 3-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E MDA&#8208;MB&#8208;231 cells were starved, stimulated with 100 ng/ml EGF for 15 or 120 min, fixed, and costained for EGFR and LAPTM4B, followed by fluorescence microscopy. Cells with higher and lower LAPTM4B expression were marked with arrows and arrowheads, respectively. F The amounts of total EGFR staining in individual cells in (E) were plotted against LAPTM4B levels at 15 min and 120 min, respectively. Note: for LAPTM4B quantification, the non&#8208;specific nuclear staining was not included. Trend lines and Pearson's correlation coefficients are shown. AU, arbitrary unit.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_4-A-B</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A MDA&#8208;MB&#8208;231 cells expressing GFP&#8208;Rab5Q79L were starved and stimulated with 100 ng/ml Alexa&#8208;555&#8208;EGF for 90 min followed by fixation and immunostaining for LAPTM4B (blue). B The percentages of luminal Alexa&#8208;555&#8208;EGF in individual endosomes were plotted against endosomal LAPTM4B levels. Trend lines and Pearson's correlation coefficients are shown. Data are representative for three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_4-C-D</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C Control or LAPTM4B knockdown MDA&#8208;MB&#8208;231 cells were starved overnight, cell surface EGFR was labeled with immuno&#8208;gold on ice. Cells were then stimulated with EGF for 1 h at 37&#176;C and fixed for the EM study. Scale bar, 200 nm. See Materials and Methods for details. D Relative amounts of immuno&#8208;gold&#8208;labeled EGFR in the MVE lumen versus MVE limiting membrane were quantified. Over 80 endosomes for each siRNA treatment from three independent experiments were used for quantification (mean + SD; ***P 0.001, one&#8208;tailed t&#8208;test).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_4-E-F</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E MDA&#8208;MB&#8208;231 cells were transfected with GFP&#8208;Rab5Q79L and Flag&#8208;LAPTM4B, starved, and stimulated with Alexa&#8208;555&#8208;EGF for 90 min and followed by intraluminal sorting analysis. See Materials and Methods for details. F Quantification of EGF localization in LAPTM4B&#8208;positive and LAPTM4B&#8208;negative endosomes in (E) (mean + SD; n = 3; ***P 0.0007, one&#8208;tailed t&#8208;test).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-A</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Co&#8208;immunoprecipitation (co&#8208;IP) of full&#8208;length or N&#8208;terminus&#8208;deleted LAPTM4B with PIPKI&#947;i5 in HEK293 cells.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-B</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B GST&#8208;tagged LAPTM4B N&#8208;terminus (93 amino acids) and T7&#8208;tagged PIPKI&#947;i5 C&#8208;terminus (223 amino acids) were purified from E. coli for in vitro GSTpull&#8208;down assay.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-C</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Co&#8208;IP of full&#8208;length or N&#8208;terminal deletion mutants of LAPTM4B with PIPKI&#947;i5 in HEK293 cells. &#8710;25: amino acids 1-25 deleted.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-E</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Coomassie Brilliant Blue staining of purified wild&#8208;type and mutated LAPTM4B N&#8208;termini.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-F</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Purified LAPTM4B N&#8208;termini from (E) were used in PIP strips assay. LPA, lysophosphatidic acid; LPC, lysophosphocholine; PE, phosphatidylethanolamine; PC, phosphatidylcholine; S1P, sphingosine 1&#8208;phosphate; PI3,4,5P3, PtdIns(3,4,5)P3, phosphatidylinositol (3,4,5)&#8208;trisphosphate; PA, phosphatidic acid; PS, phosphatidylserine.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-G</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G GSTpull&#8208;down assay of wild&#8208;type or 6RQ mutant of LAPTM4B N&#8208;termini with PIPKI&#947;i5 C&#8208;terminus.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-H</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Co&#8208;IP of wild&#8208;type or PMB&#8208;mutated LAPTM4B with wild&#8208;type or kinase dead PIPKI&#947;i5 in HEK293 cells.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-I</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I</infon>
    <passage>
      <offset>0</offset>
      <text>I Top: GSTpull&#8208;down assay of LAPTM4B N&#8208;terminus and PIPKI&#947;i5 C&#8208;terminus with increased concentration of PtdIns(4,5)P2 addition. Bottom: Quantification of the relative amounts of PIPKI&#947;i5 C&#8208;terminus bound to LAPTM4B N&#8208;terminus in top panel (mean &#177; SD; n = 4).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-J</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-J</infon>
    <infon key="sourcedata_figure_dir">Figure_5-J</infon>
    <passage>
      <offset>0</offset>
      <text>J LAPTM4B N&#8208;terminus binds multiple phosphoinositides including PtdIns(4,5)P2 in liposome&#8208;binding assay.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-K</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-K</infon>
    <infon key="sourcedata_figure_dir">Figure_5-K</infon>
    <passage>
      <offset>0</offset>
      <text>K Top: GSTpull&#8208;down assay of LAPTM4B N&#8208;terminus and PIPKI&#947;i5 C&#8208;terminus with 0.5 &#956;M addition of different phosphoinositides. Bottom: Quantification of the relative amounts of PIPKI&#947;i5 C&#8208;terminus bound to LAPTM4B N&#8208;terminus in top panel (mean + SD; n = 4).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_5-L</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 5-L</infon>
    <infon key="sourcedata_figure_dir">Figure_5-L</infon>
    <passage>
      <offset>0</offset>
      <text>L Top: GSTpull&#8208;down assay of wild&#8208;type or 6RQ mutant of LAPTM4B N&#8208;terminus and PIPKI&#947;i5 C&#8208;terminus with 0.5 &#956;M addition of PtdIns(4,5)P2. Bottom: Quantification of the relative amounts of PIPKI&#947;i5 C&#8208;terminus bound to LAPTM4B N&#8208;terminus in top panel (mean + SD; n = 4).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_6-A</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Control or LAPTM4B knockdown MDA&#8208;MB&#8208;231 cells were starved and stimulated with 100 ng/ml EGF for 30 min, and whole&#8208;cell lysates were subject to co&#8208;immunoprecipitation (co&#8208;IP) assay.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_6-B</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Control or LAPTM4B knockdown MDA&#8208;MB&#8208;231 cells were transfected with His&#8208;tagged ubiquitin, starved, and stimulated with 100 ng/ml EGF for 30 min. Total ubiquitinated proteins were purified from whole&#8208;cell lysates by Ni&#8208;NTA agarose and analyzed by Western blot.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_6-C-D</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C Control or LAPTM4B&#8208;WT/6RQ&#8208;overexpressing MDA&#8208;MB&#8208;231 cells were transfected with His&#8208;tagged ubiquitin and myc&#8208;tagged Hrs, starved, and stimulated with 100 ng/ml EGF for 30 min before whole&#8208;cell lysate harvest. Total ubiquitinated proteins were purified by Ni&#8208;NTA agarose and analyzed by Western blot. D Quantification of Hrs ubiquitination levels from the Western blot in (C) (mean + SD; n = 5).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_6-E</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E The co&#8208;IP of Myc&#8208;Hrs with Flag&#8208;LAPTM4B&#8208;WT or 6RQ mutant in HEK293 cells.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_6-F</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>F The co&#8208;IP between Hrs and Nedd4 with Flag&#8208;LAPTM4B&#8208;WT or 6RQ mutant overexpression in HEK293 cells.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_6-G</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>G The effects of LAPTM4B&#8208;6RQ mutant overexpression on EGF&#8208;stimulated EGFR degradation and signaling. Flag&#8208;LAPTM4B&#8208;WT or 6RQ mutant overexpression was accomplished by lentivirus&#8208;mediated infection approach. Cells with low levels of expression were selected as polyclonal pools for comparison. Control or overexpressing cells were starved and stimulated with 100 ng/ml EGF for indicated time periods and whole&#8208;cell lysates were analyzed by Western blot.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_6-H</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 6-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Quantification of EGFR and pAKT levels from the Western blot in (G) (mean &#177; SD; n = 5).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_6-I</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 6-I</infon>
    <infon key="sourcedata_figure_dir">Figure_6-I</infon>
    <passage>
      <offset>0</offset>
      <text>I The PY motif mutant LAPTM4B&#8208;2PA loses interaction with Nedd4 but keeps interaction with Hrs in HEK293 cells cotransfected with the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_6-J-K</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 6-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_6-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>J The effects of LAPTM4B&#8208;2PA mutant overexpression on EGF&#8208;stimulated EGFR degradation and signaling. Overexpression of Flag&#8208;LAPTM4B&#8208;WT or 2PA mutant overexpression was accomplished by lentivirus&#8208;mediated infection approach. Cells with high expression of Flag&#8208;LAPTM4B were selected as polyclonal pools for comparison. Cells were starved and stimulated with 100 ng/ml EGF for the indicated time periods, and whole&#8208;cell lysates were analyzed by Western blot. K Quantification of EGFR degradation from Western blot in (J) (mean &#177; SD; n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_7-A-B-C</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 7-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-C Co&#8208;immunoprecipitation (co&#8208;IP) of wild&#8208;type (WT) or C&#8208;terminal deletion mutants of HA&#8208;PIPKI&#947;i5 with SNX5 (A) or LAPTM4B (B and C) in HEK293 cells cotransfected with indicated proteins. &#916;675 indicates a deletion from amino acid 675 to the C&#8208;terminus.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_7-D</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D PIPKI&#947;i5 promotes SNX5 association with LAPTM4B. HEK293 cells cotransfected with indicated proteins were harvested for co&#8208;IP to assay the interaction between Myc&#8208;SNX5 and Flag&#8208;LAPTM4B.</text>
    </passage>
  </document>
  <document>
    <id>4331002 Figure_7-E</id>
    <infon key="sourcedata_document">1806</infon>
    <infon key="doi">10.15252/embj.201489425</infon>
    <infon key="pmc_id">4331002</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E SNX5 inhibits Hrs association with LAPTM4B. HEK293 cells cotransfected with indicated proteins were harvested for co&#8208;IP to assay the interaction between Myc&#8208;Hrs and Flag&#8208;LAPTM4B.</text>
    </passage>
  </document>
</collection>
